Kerem Erdoğan

Kerem Erdoğan

Auto-generated profile, based on publicly available information

Kerem Erdoğan

Hacettepe Üniversitesi

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2026 in Fabad Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
GÖGaye Öztürk
Gaye Öztürk
TATülay Özge Alpaslan
Tülay Özge Alpaslan
KEKerem Erdoğan
Kerem Erdoğan
TBTurgut Emrah Bozkurt
Turgut Emrah Bozkurt
Allergic airway diseases, including allergic asthma and rhinitis, are characterised by airway inflammation and altered responses to inhaled allergens. The endocannabinoid system (ECS) significantly contributes to the regulation of airway tone and immune system activity. Experimental studies indicate that cannabinoid receptor ligands and inhibitors of endocannabinoid metabolism can modify airway hyperreactivity, inflammatory cell recruitment, and allergic inflammation. However, these effects are not uniform. CB1 and CB2 receptor signalling may produce different outcomes depending on the ligand, responding cell population, tissue, and experimental model. Endocannabinoid-related lipids may likewise exert protective or pro-inflammatory effects through different pathways. Evidence for therapeutic targeting of the ECS is more extensive in allergic asthma, where improvements in airway function or inflammation have been reported. In allergic rhinitis, pharmacological evidence remains limited, and the available clinical findings are insufficient to draw definitive conclusions. The established data suggests the ECS as a potential target in allergic airway diseases while underscoring the need to clarify receptor-dependent and receptor-independent mechanisms mediating their effects and establish efficacy and safety in well-characterized human populations. This review focuses on the role of the ECS in allergic airway diseases and evaluates its potential as a therapeutic target.